Skip to main content
SpringerLink
Log in

ASO Author Reflections: Is There a Role for Selective Adjuvant Radiotherapy in the Modern Era of Pancreatic Cancer Treatment?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aquina CT, Ejaz A, Tsung A, Pawlik TM, Cloyd JM. National trends in the use of neoadjuvant therapy before cancer surgery in the US from 2004 to 2016. JAMA Netw Open. 2021;4:e211031. https://doi.org/10.1001/jamanetworkopen.2021.1031.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Katz MHG, Shi Q, Meyers J, et al. Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the a021501 phase 2 randomized clinical trial. JAMA Oncol. 2022. https://doi.org/10.1001/jamaoncol.2022.2319.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sohal DPS, Duong M, Ahmad SA, et al. Efficacy of perioperative chemotherapy for resectable pancreatic adenocarcinoma: a phase 2 randomized clinical trial. JAMA Oncol. 2021;7:421–7. https://doi.org/10.1001/jamaoncol.2020.7328.

    Article  PubMed  Google Scholar 

  4. Del Chiaro M, Sugawara T, Karam SD, Messersmith WA. Advances in the management of pancreatic cancer. BMJ. 2023;383:e073995. https://doi.org/10.1136/bmj-2022-073995.

    Article  PubMed  Google Scholar 

  5. Franklin O, Sugawara T, Blake Ross R, et al. Adjuvant chemotherapy with or without radiotherapy for resected pancreatic cancer following multiagent neoadjuvant chemotherapy. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15157-4.

    Article  Google Scholar 

  6. Piper M, Hoen M, Darragh LB, et al. Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis. Cancer Cell. 2023;41:950-69.e6. https://doi.org/10.1016/j.ccell.2023.04.001.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA

    Oskar Franklin MD, PhD, Richard D. Schulick MD, MBA, FACS & Marco Del Chiaro MD, PhD, FACS

  2. Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden

    Oskar Franklin MD, PhD

  3. Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA

    Sana Karam MD, PhD

  4. University of Colorado Cancer Center, Aurora, CO, USA

    Sana Karam MD, PhD, Richard D. Schulick MD, MBA, FACS & Marco Del Chiaro MD, PhD, FACS

Authors
  1. Oskar Franklin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sana Karam MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard D. Schulick MD, MBA, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Del Chiaro MD, PhD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oskar Franklin MD, PhD.

Ethics declarations

Disclosures

Dr. Del Chiaro has received an industry grant (Haemonetics, Inc) to conduct a multicenter study. Dr. Del Chiaro is the principal investigator of a Boston Scientific-sponsored international multicenter study. Dr. Karam receives clinical funding from Genentech, Ionis, and AstraZeneca. Dr. Karam also receives preclinical research funding from Roche. Dr. Schulick is a coinventor of a patent licensed to DynamiCure (managed by the University of Colorado) outside the submitted work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article refers to Franklin O, Sugawara T, Blake Ross R, et al. Adjuvant chemotherapy with or without radiotherapy for resected pancreatic cancer following multiagent neoadjuvant chemotherapy. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15157-4.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Franklin, O., Karam, S., Schulick, R.D. et al. ASO Author Reflections: Is There a Role for Selective Adjuvant Radiotherapy in the Modern Era of Pancreatic Cancer Treatment?. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15297-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1245/s10434-024-15297-7

Search

Navigation